Hong Tao

Jan 15, 2025 | mdpi.com | Hong Tao |Yukun Zhao |Qiang Zhang |Xu Li

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Sep 10, 2024 | bmccancer.biomedcentral.com | Wei Li |Hong Tao |Hai Liang |Fang Ting

ReferencesSung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660. Article  PubMed  CAS  Google Scholar  Jin ZC, Zhong BY, Chen JJ, Zhu HD, Sun JH, Yin GW, et al. Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study. Eur Radiol. 2023;33:8669–81.

Jul 21, 2024 | mdpi.com | Jinxi Li |Hong Tao

This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Jinxi Li SciProfiles Scilit Preprints.org Google Scholar and Hong Tao SciProfiles Scilit Preprints.org Google Scholar * College of Science, National University of Defense Techonology, Changsha 410072, China *Author to whom correspondence should be addressed.

Apr 29, 2023 | paperity.org | Hong Tao

npj Quantum Information, Apr 2023 This is a preview of a remote PDF: https://www.nature.com/articles/s41534-023-00697-6.pdf Mukhopadhyay, Priyanka, Wiebe, Nathan, Zhang, Hong Tao. , npj Quantum Information, DOI: 10.1038/s41534-023-00697-6